Quarterly report [Sections 13 or 15(d)]

Consolidated Balance Sheets - (Unaudited)

v3.25.1
Consolidated Balance Sheets - (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 36,740 $ 53,322
Cash held in escrow 15,563 3,921
Real estate inventories 1,326,498 1,339,082
Due from affiliates 553 419
Goodwill 155,597 155,597
Other assets 147,431 148,996
Total assets 1,682,382 1,701,337
Liabilities    
Accounts payable 86,966 86,348
Accrued expenses and other liabilities 197,703 212,645
Due to affiliates 887 881
Line of credit facility, net  195,330 194,435
Senior notes, net 532,177 530,919
Total liabilities 1,013,063 1,025,228
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Preferred stock, $0.0001 par value, 50,000,000 shares authorized, none issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 0 0
Common stock, $0.0001 par value, 500,000,000 shares authorized, 41,798,858 issued and 36,402,863 outstanding as of March 31, 2025, 41,712,850 issued and 36,316,855 outstanding as of December 31, 2024 4 4
Additional paid-in capital 462,709 462,363
Retained earnings 197,561 204,815
Total stockholders’ equity 660,274 667,182
Noncontrolling interests 9,045 8,927
Total equity 669,319 676,109
Total liabilities and equity $ 1,682,382 $ 1,701,337